BioMark Diagnostics Inc.
BUX
CNSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.73M | 61.60K | 25.60K | 103.30K | 115.80K |
Total Receivables | 111.80K | 49.20K | 49.90K | 22.70K | 31.80K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.84M | 110.80K | 75.60K | 125.90K | 147.50K |
|
|||||
Total Current Assets | 1.84M | 110.80K | 75.60K | 125.90K | 147.50K |
Net Property, Plant & Equipment | 315.90K | 472.50K | 546.60K | 582.00K | 629.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 24.10K | 23.70K | 25.30K | 25.00K | 25.20K |
Total Assets | 2.18M | 609.30K | 649.80K | 735.20K | 804.20K |
|
|||||
Total Accounts Payable | 186.10K | 330.60K | 307.80K | 108.80K | 106.70K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 461.50K | 656.10K | 631.00K | 567.40K | 546.40K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 204.20K | 64.20K | 134.30K | 235.20K | 259.80K |
Total Finance Division Other Current Liabilities | 5.80K | 5.80K | 6.20K | 6.10K | 6.20K |
Total Other Current Liabilities | 5.80K | 5.80K | 6.20K | 6.10K | 6.20K |
Total Current Liabilities | 857.60K | 1.06M | 1.08M | 917.60K | 919.00K |
|
|||||
Total Current Liabilities | 857.60K | 1.06M | 1.08M | 917.60K | 919.00K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 461.50K | 656.10K | 631.00K | 567.40K | 546.40K |
Capital Leases | 111.80K | 315.60K | 336.20K | 292.30K | 335.40K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 969.40K | 1.37M | 1.42M | 1.21M | 1.25M |
|
|||||
Common Stock & APIC | 12.19M | 9.19M | 9.78M | 9.57M | 9.22M |
Retained Earnings | -10.97M | -10.67M | -11.12M | -10.57M | -9.93M |
Treasury Stock & Other | -- | 716.10K | 573.60K | 528.90K | 258.50K |
Total Common Equity | 1.21M | -763.00K | -765.70K | -474.60K | -450.20K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.21M | -763.00K | -765.70K | -474.60K | -450.20K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.21M | -763.00K | -765.70K | -474.60K | -450.20K |
|